Aspirion CEO Nick Giannasi said in a Dec. 18 news release that Boost Healthcare’s expertise in zero-balance review, payment variance, denials management, and No Surprises Act compliance “strengthens Aspirion’s ability to transform healthcare financial operations.”
“By combining Boost’s deep expertise with our technology and AI, we are exponentially scaling our capacity to secure the rightful reimbursement for healthcare providers,” Mr. Giannasi said.
The latest acquisition marks Aspirion’s seventh in six years, according to the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
